Evidences regarding the effectiveness of adipose-derived mesenchymal stem cells (ADMSCs) secretome to alleviate skin aging have been extensively available, yet no studies hitherto directly investigated the best administration technique for such purpose. The objective of this study is to compare microneedling and fractional CO₂ laser methods in administrating ADMSCs secretome for facial skin rejuvenation of Indonesian adult women.
Age range
35 Years – 59 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Skin aging changes evaluated by dermoscopy photoaging scale (DPAS)
Timeframe: Week 0 (baseline), week 2 before intervention, week 4 before intervention, week 6 (end of trial)
Skin aging changes evaluated by Janus-3Ⓡ skin analyzer
Timeframe: Week 0 (baseline), week 2 before intervention, week 4 before intervention, week 6 (end of trial)
Skin capacitance evaluated by the CorneometerⓇ
Timeframe: Week 0 (baseline), week 2 before intervention, week 4 before intervention, week 6 (end of trial)
Transepidermal water loss evaluated by the TewameterⓇ
Timeframe: Week 0 (baseline), week 2 before intervention, week 4 before intervention, week 6 (end of trial)